BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7199300)

  • 21. [Adenosine degradation in human erythrocytes in the presence of dilazep].
    Blum KU; Merkel R
    Arzneimittelforschung; 1976; 26(9):1638-42. PubMed ID: 1036691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global and regional haemodynamic effects of urapidil in conscious dogs with chronic coronary artery occlusion.
    Wouters PF; Marcus MA; Van Aken HK; van de Velde M; Miserez M; Deruyter HA; Mignolet K; Flameng W
    Eur J Anaesthesiol; 1994 Sep; 11(5):381-90. PubMed ID: 7988582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of dilazep on cerebral blood flow under normal conditions and recirculation impairment after cerebral ischemia (author's transl)].
    Kondo S; Kawada M; Sano N
    Nihon Yakurigaku Zasshi; 1981 Feb; 77(2):205-11. PubMed ID: 7239362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of immature recruitable collaterals on myocardial blood flow and infarct size after acute coronary occlusion.
    Ramanathan KB; Wilson JL; Ingram LA; Mirvis DM
    J Lab Clin Med; 1995 Jan; 125(1):66-71. PubMed ID: 7822947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dilazep on coronary and systemic hemodynamics in humans.
    Marzilli M; Simonetti I; Levantesi D; Trivella MG; De Nes M; Perissinotto A; Puntoni R; Buzzigoli G; Boni C; Michelassi C
    Am Heart J; 1984 Aug; 108(2):276-85. PubMed ID: 6431792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of dilazep on the myocardium and smooth vascular muscle].
    Cargnoni A; Gargano M; PelĂ  G; Gallo P; Ferrari R; Raddino R
    Cardiologia; 1987 Oct; 32(10):1161-5. PubMed ID: 3690582
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of adenosine compounds of the vascular bed and effects of dilazep, theophylline, and indomethacin on blood flow changes of the postocclusive renal vessels].
    Ohtaki Y; Nakanishi H; Ueda J
    Nihon Yakurigaku Zasshi; 1977 Jan; 73(1):93-102. PubMed ID: 558949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of dilazep on myocardial contractility following acute ischemia and reperfusion in isolated blood-perfused canine left ventricular muscle.
    Shida H; Kobayashi M; Chiba S
    Jpn Heart J; 1981 Jul; 22(4):665-78. PubMed ID: 6457922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of dilazep on blood flow and oxygen handling in the early stages of canine myocardial infarction. Simultaneous comparison with changes in the normal myocardium.
    Marshall RJ; Parratt JR
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 281(4):427-36. PubMed ID: 4275262
    [No Abstract]   [Full Text] [Related]  

  • 30. A study on dilazep: I. Mechanism of anti-ischemic action of dilazep is not coronary vasodilation but decreased cardiac mechanical function in the isolated, working rat heart.
    Hoque AN; Hoque N; Hashizume H; Abiko Y
    Jpn J Pharmacol; 1995 Mar; 67(3):225-32. PubMed ID: 7630040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human platelet aggregation tests in vitro. Effects of dilazep.
    Ponari O; Manotti C
    Arzneimittelforschung; 1981; 31(1):97-101. PubMed ID: 7194099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central nervous system effects and behavioral interactions with ethanol of centrally administered dilazep and its metabolites in mice.
    Dar MS
    Eur J Pharmacol; 1989 May; 164(2):303-13. PubMed ID: 2759178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of dilazep in evolving myocardial infarction in dogs: a biochemical study.
    Gupta JB; Seth SD; Singh U; Vyas DS
    Int J Cardiol; 1989 May; 23(2):165-71. PubMed ID: 2542170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of dilazep on shape change of human erythrocyte in blood stored over a period of 42 days.
    Fujisawa Y; Abiko Y
    Arzneimittelforschung; 1981; 31(9):1462-8. PubMed ID: 7197956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three dimensional geometry of acutely ischemic myocardium.
    Marcus ML; Kerber RE; Ehrhardt J; Abboud FM
    Circulation; 1975 Aug; 52(2):254-63. PubMed ID: 1149207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dilazep].
    Pirani R; Gruppillo P
    G Ital Cardiol; 1980; 10(10):1419-25. PubMed ID: 7016654
    [No Abstract]   [Full Text] [Related]  

  • 37. Renal vascular effects of dilazep antagonized by 3-isobutyl-1-methyl-xanthine.
    Yukimura T; Miura K; Ito K; Yamamoto K
    J Cardiovasc Pharmacol; 1986; 8(3):649-55. PubMed ID: 2425186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of dilazep on circulating platelet aggregation in diabetics].
    Carleo R; Buda GR; Cerciello A; Dell'Aversano R; Monaco GP; Trovato C; Vigilante M
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1832-7. PubMed ID: 6671042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of dilazep on fibrinolytic system in animals. II. Enhancing effect of dilazep on plasminogen activator release in the isolated perfused pig ear.
    Nakajima K
    J Pharmacobiodyn; 1982 May; 5(5):363-9. PubMed ID: 6889645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of coronary vasodilating action of adenosine by dilazep and dipyridamole in the dog.
    Sano N
    Jpn J Pharmacol; 1974 Jun; 24(3):471-8. PubMed ID: 4449152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.